Side Effects of Q-Switched Ruby Laser for the Treatment of Lentigines in Light and Dark Skin Types
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00386204|
Recruitment Status : Completed
First Posted : October 11, 2006
Last Update Posted : June 4, 2008
|Condition or disease||Intervention/treatment||Phase|
|Solar Lentigines||Device: Q-switched Ruby Laser||Phase 2|
It has been widely accepted that dark colored individuals are prone to develop laser induced side effects especially post inflammatory hyperpigmentation(PIH) and it could be a limiting issue in selecting dark colored individuals.
We designed this study to evaluate the difference of efficacy and side effects in light and dark skinned individuals.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||90 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||Efficacy and Side Effects of Q-Switched Ruby Laser Treatment of Solar Lentigines in Two Different Fitzpatrick Skin Types II and IV|
|Study Start Date :||November 2005|
|Estimated Study Completion Date :||September 2006|
- Clinical Clearance
- Side Effects
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00386204
|Iran, Islamic Republic of|
|Skin Research Center, Shohada-e Tajrish Hospital, Shaheed Beheshti Medical University|
|Tehran, Iran, Islamic Republic of, 19899|
|Study Chair:||Parviz Toossi, M.D.||Shahid Beheshti University of Medical Sciences|